A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes

A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes

Information from the National Library of Medicine
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05791201

Contacts

Locations

Layout table for location information

United States, Florida

UHealth Diabetes Research Institute
**RECRUITING NOW**

Miami, Florida, United States, 33136

Canada

University of Alberta, Edmonton
**RECRUITING NOW**

Edmonton, Canada

Netherlands

Leiden University
**RECRUITING NOW**

Leiden, Netherlands

Sponsors and Collaborators
Vertex Pharmaceuticals Incorporated

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 28, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments